Retour
Unicycive Therapeutics Inc (UNCY) Gagner
Graphique du cours de l'action UNCY
UNCY Gagner
Unicycive Therapeutics Inc
$6.93
-2.66%
$-0.19
À la fermeture : Apr 02, 16:00:00 GMT-4
$7
1.14%
$0.07
Post-Marché: Apr 02, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$7.12
Prix d'ouverture
$6.99
Plage de la journée
$6.76 - $7.08
Plage de 52 semaines
$3.71 - $11
Volume
487.4K
Volume moyen
558.2K
Rendement en dividend
--
BPA (TTM)
-2.97
Capitalisation boursière
$150.6M
Qu’est-ce que UNCY ?
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. The company is headquartered in Los Altos, California and currently employs 22 full-time employees. The company went IPO on 2021-06-17. The firm's lead drug candidate, oxylanthanum carbonate (OLC), is an investigational phosphate binding agent being developed for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis. Its second asset, UNI-494, is a patent-protected new chemical entity in clinical development for the treatment of conditions related to acute kidney injury.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.